Company founded by CWRU’s Paul Tesar, Drew Adams partners with Genentech

CWRU spinout Convelo partners with San Francisco company to develop medicines for neurological disorders

Crain’s Cleveland Business: A company founded by and based on the research findings of Paul Tesar, the Dr. Donald and Ruth Weber Goodman Professor of Innovative Therapeutics, and Drew Adams, the Thomas F. Peterson Jr. Professor of Novel Therapeutics, recently partnered with Genentech to develop new medications for patients with neurological disorders.